Kuehn Law Encourages Investors of Travere Therapeutics, Inc. to Contact Law Firm

Kuehn Law is investigating whether officers and directors of Travere Therapeutics breached fiduciary duties to shareholders through potential self-dealing. Long-term shareholders may be entitled to damages and corporate governance reforms.